Brief: Diasorin Receives Approval For HDV Laboratory Test In The U.S.
29/01/2026 06:08
Jan 29 (Reuters) - DiaSorin SpA DIAS.MI: DIASORIN RECEIVES DE NOVO APPROVAL IN THE UNITED STATES FOR THE FIRST FULLY AUTOMATED LABORATORY TEST FOR HEPATITIS DELTA VIRUS (HDV) ON THE LIAISON XL SYSTEM FULLY AUTOMATED HDV IMMUNOASSAY TEST ON DIASORIN LIAISON XL TO BE AVAILABLE IN THE U.S. STARTING FEB 2026 Further company coverage: DIAS.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on DiaSorin SpA
See all newsKepler sees European Medtech recovery, starts BioMerieux at 'Buy' as top pick
Brief: Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay
Deutsche Bank cuts Diasorin to 'sell', sees company targets as stretched
Italy - Factors to watch on June 5
Italy's DiaSorin jumps after Betaville reports possible takeover interest